Loading…
Loading…
EQUITY / NASDAQ · XNCM
NewGenIvf Group Limited Class A Ordinary Shares
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2025 – 12/31/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.1264 USD · -2.0155%
Observed: Oct 2, 2026, 11:59 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/02/2026 · 0.129 USD · Volume 303,282,330
20 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2025 – 12/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 4,726,433 USD | 5,433,375 USD | -13.01% |
| Operating profit | -10,726,461 USD | -1,160,495 USD | — |
| Net income | 9,879,408 USD | -524,643 USD | — |
| Operating cash flow | -10,926,056 USD | -8,264,074 USD | — |
| Cash and cash equivalents | 758,621 USD | 457,740 USD | +65.73% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · USD | 2023 / Year end01/01/2023 – 12/31/2023ConsolidatedUnits · USD |
|---|---|---|---|
| Capital expendituresCash flow statement | 135,025 USD | 53,045 USD | 69,848 USD |
| Cash and cash equivalentsBalance sheet | 758,621 USD | 457,740 USD | — |
| Financing cash flowCash flow statement | 18,992,758 USD | 8,675,790 USD | 1,881,493 USD |
| Gross profitIncome statement | 955,846 USD | 1,826,894 USD | 1,681,785 USD |
| Investing cash flowCash flow statement | -7,559,774 USD | -53,045 USD | -69,848 USD |
| Net incomeIncome statement | 9,879,408 USD | -524,643 USD | 130,193 USD |
| Operating cash flowCash flow statement | -10,926,056 USD | -8,264,074 USD | -1,766,135 USD |
| Operating profitIncome statement | -10,726,461 USD | -1,160,495 USD | 42,242 USD |
| RevenueIncome statement | 4,726,433 USD | 5,433,375 USD | 5,136,153 USD |
| Total assetsBalance sheet | 32,722,769 USD | 3,577,744 USD | — |
| Total equityBalance sheet | 26,631,519 USD | -1,048,614 USD | 3,245,561 USD |
| Total liabilitiesBalance sheet | 6,736,076 USD | 5,059,501 USD | — |
| Report source | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 05/15/2025 | Open report ↗ Published: 03/31/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.